Cited by 10Metabolism and Genetic DisordersLipid metabolism and biosynthesisLysosomal Storage Disorders Research

Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation

Noguchi, Masafumi, Honsho, Masanori, Abe, Yuichi, Toyama, Ryusuke, Niwa, Hajime, Sato, Yoshiteru, Ghaedi, Kamran, Rahmanifar, Ali +2 more·2014·Journal of Human Genetics

Abstract

Rhizomelic chondrodysplasia punctata (RCDP) is an autosomal recessive disorder due to the deficiency in ether lipid synthesis. RCDP type 1, the most prominent type, is caused by the dysfunction of the receptor of peroxisome targeting signal type 2, Pex7 (peroxisomal biogenesis factor 7), and the rest of the patients, RCDP types 2 and 3, have defects in peroxisomal enzymes catalyzing the initial two steps of alkyl-phospholipid synthesis, glyceronephosphate O-acyltransferase and alkylglycerone phosphate synthase (Agps). We herein investigated defects of two patients with RCDP type 3. Patient 1 had a novel missense mutation, T1533G, resulting in the I511M substitution in Agps. The plasmalogen level was mildly reduced, whereas the protein level and peroxisomal localization of Agps-I511M in fibroblasts were normal as in the control fibroblasts. Structure prediction analysis suggested that the mutated residue was located in the helix α15 on the surface of V-shaped active site tunnel in Agps, likely accounting for the mild defects of plasmalogen synthesis. These results strongly suggest that an individual with mildly affected level of plasmalogen synthesis develops RCDP. In fibroblasts from patient 2, the expression of AGPS mRNA and Agps protein was severely affected, thereby giving rise to the strong reduction of plasmalogen synthesis.

Integrity signals

Registry

Crossref · 10.1038/jhg.2014.39

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RCDP severity varies remarkably and depends strongly on residual activity of the affected enzyme and thus the level of plasmalogens.

    “The severity of the disease varies remarkably, depending strongly on the residual activity of the affected enzyme and, thus, the level of plasmalogens [188–191].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [188]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Noguchi, M., Honsho, M., Abe, Y., Toyama, R., Niwa, H., Sato, Y., Ghaedi, K., Rahmanifar, A., Shafeghati, Y., & Fujiki, Y.
Affiliations
  • Kyushu University (JP)
  • Royan Institute (IR)
  • Sarem Cell Research Center (IR)
Corresponding author
Fujiki, Yukio
Venue
Journal of Human Genetics
Published
2014-05-22
Volume
59
Issue
7
Pages
387-392
ISSN
  • 1434-5161 (ISSN-L)
  • 1435-232X
OpenAlex
W2026539650
Cited by
10
References
25
Citations by year
2026: 1 · 2024: 1 · 2021: 2 · 2020: 1 · 2018: 2 · 2017: 1 · 2015: 2
FWCI
0.69
Type
journal article
Language
en
Update notices
erratum (2014-07-25)
Open access
closed
Locations
  • Journal of Human Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Japan Foundation for Applied Enzymology
  • Ministry of Education, Culture, Sports, Science and Technology (24247038, CREST)
  • Japan Society for the Promotion of Science (25112518, 26440032, 25440030, 26440102, 19058011, 24247038, CREST, 26116007, 23570236, 20370039, 25116717)
  • Japan Science and Technology Agency (24247038, 25116717, CREST)
  • Core Research for Evolutional Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
rhizomelic chondrodysplasia punctata, plasmalogens, peroxisome biogenesis, peroxisomal disorders, fibroblasts, protein structure prediction
MeSH terms
Cell Line, Child, Preschool, DNA Mutational Analysis, Female, Fibroblasts, Humans, Models, Molecular, Mutation, Plasmalogens, Protein Conformation, RNA, Messenger, Gene Expression, Chondrodysplasia Punctata, Rhizomelic, Alkyl and Aryl Transferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review